+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Nortrachelogenin

SBP01337
34444-37-6
98%
普瑞法
Nortrachelogenin is a novel agent for prostate cancer therapy with ability to inhibit Akt membrane localization and activity as well as the activation of growth factor receptors, thereby efficiently synergizing with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), exposure.Nortrachelogenin has anti-inflammatory properties,it shows moderate inhibiting activities on NF- κB signaling pathway induced by TNF-α , with the IC50 value of 49.4 uM. Nortrachelogenin also shows anti-plasmodium activity of 14.50 dg/ml. (+ )-Nortrachelogenin shows effects on the central nervous system producing depression in rabbits, it is moderately active against HIV-1 in vitro. (-)-Nortrachelogenin exerts its antibacterial effect by disorganizing and perturbing the cytoplasmic membrane, it also can induce membrane disruption and caspase-dependent apoptosis.
Catalog No Package Original Price Price Inventory Quantity Operating
SBP01337-5mg 5mg
SBP01337-10mg 10mg
SBP01337-20mg 20mg
SBP01337-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Nortrachelogenin Related Products

Product drug property prediction parameters

  • 105.4500

  • 2.0747

  • 2.0716

  • .1996

  • 4.1913

  • 2.2799

  • Low

  • 87.7322

  • 3.3632

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • No